SERA
Sera Prognostics Inc
NASDAQ: SERA · HEALTHCARE · MEDICAL DEVICES
$1.99
+0.51% today
Updated 2026-04-29
Market cap
$77.93M
P/E ratio
—
P/S ratio
962.05x
EPS (TTM)
$-0.67
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Sera Prognostics Inc (SERA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-19.32M | $-16.87M | $-31.64M | $-34.61M | $-27.19M | $-14.19M | $-25.62M |
| Capital expenditures | $109000.00 | $149000.00 | $1.30M | $791000.00 | $128000.00 | $1.10M | $726000.00 |
| Depreciation | $946000.00 | $895000.00 | $659000.00 | $756000.00 | $900000.00 | $833000.00 | — |
| Stock-based comp | $438000.00 | $726000.00 | $3.13M | $5.05M | $5.27M | $7.01M | $5.11M |
| Free cash flow | $-19.43M | $-17.02M | $-32.94M | $-35.40M | $-27.32M | $-15.29M | $-26.35M |
| Investing cash flow | $-6000.00 | $-149000.00 | $-82.56M | $5.55M | $438000.00 | $11.74M | — |
| Financing cash flow | $33.05M | $9.16M | $159.59M | $5000.00 | $752000.00 | $2.61M | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $45.40M | $-29.05M | — | — | — |